Account
Inquiry
Tirzepatide (LY3298176) is a dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist developed for type 2 diabetes research. This white powder formulation shows superior efficacy in glucose control and weight management compared to similar compounds.
Our pharmaceutical-grade tirzepatide features 99.9% purity and is supplied in convenient 10mg vials (10 vials/box). The compound has demonstrated significant weight loss results in clinical studies, with average reductions of 15-20% body weight at different dosage levels.
As a research chemical, tirzepatide offers scientists a powerful tool for studying metabolic disorders. The molecule combines the effects of two important incretin hormones into a single compound, representing an innovative approach to diabetes research.
Key advantages of our tirzepatide supply include strict GMP manufacturing standards, batch-to-batch consistency, and comprehensive quality control documentation. We support both small-scale research needs and large bulk orders with flexible packaging options.
For researchers looking to buy tirzepatide, we offer competitive pricing structures for academic institutions, pharmaceutical companies, and research organizations. Our team can provide technical support and custom synthesis services for specialized research requirements.
Please note: This product is intended for research purposes only. Not for human consumption or diagnostic use. Proper safety protocols should be followed when handling this material.
